As you most likely have heard, Oregon residents voted in 2020 to legalize a regulated psilocybin therapy program in their state, and that program is going live this year. The first class of facilitators trained specifically to facilitate in licensed Oregon centers just graduated, and with facilities, growers, and facilitators all being licensed now or in the near future, Oregon is looking to be up and running (and facilitating psilocybin sessions) very soon.
Imagine you are (or perhaps you actually are) a primary care provider in Oregon, and a medically complex patient arrives in your office asking if it is safe for them to undergo psilocybin therapy.
Would you know how to respond?
As most of us weren’t taught anything about psilocybin in our training, and due to the paucity of research on how psilocybin affects our physiology, most of us would feel likely feel poorly equipped to help this patient.
Now before you think that this only applies to Oregon, Colorado has recently passed a similar measure that will allow facilitated psilocybin therapy in the coming years, and measures like these are starting to appear in legislatures and on ballots across the country, so wherever you live may see similar changes in the not-too-distant future.
So, to educate primary care clinicians in Oregon and beyond, the Psychedelic Medicine Association has created its first course: Managing Medical Risk in Patients Seeking Psilocybin Therapy.
And this month we gathered some of the experts behind the course to tell you both about how exactly the Oregon psilocybin program will work, and some of the medical considerations that you’ll learn about in the course.
They’ll helped elucidate:
- Who can access psilocybin in Oregon
- What kind of training the facilitators will undergo and what the facilities may be like
- What types of indications psilocybin may be helpful for
- Some of the considerations in managing medical risk for patients seeking psilocybin therapy


